Ministry of Health presents Allergarda allergy vaccine

The Ministry of Health has officially presented the new Allergarda vaccine, designed to treat pollen allergies. The drug was developed with the aim of completely blocking symptoms such as sneezing, itching, and irritation of mucous membranes during the active flowering period of plants.

The mechanism of action is based on preventing an allergic reaction before it begins. The vaccine contains a special protein containing fragments of birch and apple allergens. This allows the body to develop protection against specific triggers.

The effectiveness of the drug extends not only to respiratory manifestations but also to cross-food allergies. The use of 'Allergarda' promises to significantly improve the lives of people suffering from seasonal and food allergic reactions.